Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

Integritas Communications

JAK Inhibition in Rheumatoid Arthritis

Access Activity

Overview / Abstract:

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.

Expiration

Oct 29, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

0.25

Accreditation

ACCME, CE, CME

Presenters / Authors / Faculty

Allan Gibofsky, MD, JD, MACR, FACP, FCLM; Bruce E. Sands, MD, MS

Sponsors / Supporters / Grant Providers

This activity is jointly provided by Global Education Group and Integritas Communications.

Based on a live symposium supported by an educational grant from Gilead Sciences, Inc.

Keywords / Search Terms

Integritas Communications gastroenterologists, rheumatologists, JAK, CME, CE Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.